Medasense headlines “Anesthesiology News” – the most-read publication by anesthesiologists in the USA
The article reports on clinical trial results previously published in Anesthesiology in 2016, with insightful interviews from lead investigators, Dr. Daniel Sessler (Head of Center of Outcomes Research, Cleveland Clinic, Ohio, USA) and Dr. Ruth Edry (Department of Anesthesiology, Rambam Medical Centre, Haifa, Israel).
Medasense featured in the Journal of Anesthesia Practice
Medasense featured in the Journal of Anesthesia Practice, following the launch of its CE-approved Pain Monitoring Device, PMD-200™, in January.
Medasense Launches New Pain Monitoring Device, PMD200™ following European CE approval
Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200™. This new technology is now available to help physicians objectively assess a patient’s pain in critical care situations, where
December 2016 – Israeli Society of Anesthesiology Annual Meeting
Join us at the annual meeting of the Israel Society of Anesthesiologists while we exhibit the novel NOL™ (Nociception Level) Index – a breakthrough in objective intraoperative pain monitoring (Dec 15-16, Tel-Aviv).
May 2016 – ASA’s Press Release About Dr. Ruth Edry and Prof. Daniel Sessler’s study
The American Society of Anesthesiologists (ASA) publicized Medasense’s latest study, led by Dr. Ruth Edry and co-authored by Prof. Daniel Sessler,
TV Interview with Medasense CEO on Channel 1 (Israel)
Check out the TV interview with CEO, Galit Zuckerman, on Channel 1 (Israel) explaining how Medasense’s proprietary technology can measure pain objectively (Hebrew).